Literature DB >> 31909440

Anti-Inflammation Associated Protective Mechanism of Berberine and its Derivatives on Attenuating Pentylenetetrazole-Induced Seizures in Zebrafish.

Baoyue Zhang1,2, Lizhen Wang1,2, Xiuna Ji1,2, Shanshan Zhang1,2, Attila Sik3,4,5, Kechun Liu1,2, Meng Jin6,7.   

Abstract

Epileptic seizures are characterized by synchronized discharges of neurons, leading to the activation of inflammatory responses that in turn contributes to seizure progression. Berberine (BBR), a bioactive constituent extracted from berberis, has been known to relieve seizures in rodent models. In this study, we synthesized two derivatives of berberine (BBR-D1 and BBR-D2) to compare their seizure reducing effect with BBR in pentylenetetrazole (PTZ)-induced seizures in zebrafish. We found a structure-activity relationship between hydrophilic/hydrophobic composition of the derivatives and their anticonvulsant activity. We also investigated the underlying mechanism related to their anti-inflammatory effect during seizures. BBR and its derivatives increased the seizure onset latency and suppressed the seizure-like behavior after PTZ treatment. Zebrafish larvae pretreated with BBR and its derivatives showed recovery on c-fos expression and neuronal discharges during seizures. The inflammatory responses occurred during the progression of seizures, including the recruitment of macrophages and neutrophils as well as an up-regulation of tumor necrosis factor alpha (TNFα), interleukin 1 beta (il1β), and interleukin 6 (il6). This effect was significantly suppressed by the pretreatment of BBR and its derivatives. Our results suggest that BBR and its derivatives attenuate PTZ-induced seizures and modulate anti-inflammatory effect to potentially protect zebrafish from the occurrence of further seizures. From the tested compounds, BBR-D1 (the hydrophilic berberrubine) showed the strongest seizure reducing effect. Graphical Abstract Two derivatives of berberine (BBR-D1 and BBR-D2) were synthesized to compare their seizure reducing effect with BBR in pentylenetetrazole (PTZ)-induced seizures in zebrafish. BBR and its derivatives increased the seizure onset latency and suppressed the seizure-like behavior after PTZ treatment. Zebrafish larvae pretreated with BBR and its derivatives showed recovery on c-fos expression and neuronal discharges during seizures. The inflammatory responses occurred during the progression of seizures, including the recruitment of macrophages and neutrophils as well as an up-regulation of tumor necrosis factor alpha (TNFα), interleukin 1 beta (il1β), and interleukin 6 (il6). This effect was significantly suppressed by the pretreatment of BBR and its derivatives.

Entities:  

Keywords:  Anti-inflammation; Anticonvulsant; Berberine; Epilepsy; PTZ; Zebrafish

Mesh:

Substances:

Year:  2020        PMID: 31909440     DOI: 10.1007/s11481-019-09902-w

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  7 in total

Review 1.  Berberine and its derivatives represent as the promising therapeutic agents for inflammatory disorders.

Authors:  Qiukai Lu; Yifan Fu; Heng Li
Journal:  Pharmacol Rep       Date:  2022-01-27       Impact factor: 3.024

2.  Anti-epileptic Kunitz-like peptides discovered in the branching coral Acropora digitifera through transcriptomic analysis.

Authors:  Hanbin Chen; Shirley Weng In Siu; Clarence Tsun Ting Wong; Jianwen Qiu; Alex Kwok-Kuen Cheung; Simon Ming Yuen Lee
Journal:  Arch Toxicol       Date:  2022-05-23       Impact factor: 6.168

3.  The Influence of Palmatine Isolated from Berberis sibirica Radix on Pentylenetetrazole-Induced Seizures in Zebrafish.

Authors:  Kinga Gawel; Wirginia Kukula-Koch; Dorota Nieoczym; Katarzyna Stepnik; Wietske van der Ent; Nancy Saana Banono; Dominik Tarabasz; Waldemar A Turski; Camila V Esguerra
Journal:  Cells       Date:  2020-05-16       Impact factor: 6.600

4.  Possible involvement of TGF‑β‑SMAD‑mediated epithelial‑mesenchymal transition in pro‑metastatic property of PAX6.

Authors:  Meng Jin; Daili Gao; Rongchun Wang; Attila Sik; Kechun Liu
Journal:  Oncol Rep       Date:  2020-06-11       Impact factor: 3.906

5.  Anti-High Mobility Group Box-1 Monoclonal Antibody Attenuates Seizure-Induced Cognitive Decline by Suppressing Neuroinflammation in an Adult Zebrafish Model.

Authors:  Yam Nath Paudel; Iekhsan Othman; Mohd Farooq Shaikh
Journal:  Front Pharmacol       Date:  2021-03-01       Impact factor: 5.810

Review 6.  Therapeutic Efficacies of Berberine against Neurological Disorders: An Update of Pharmacological Effects and Mechanisms.

Authors:  Jia-Wen Shou; Pang-Chui Shaw
Journal:  Cells       Date:  2022-02-24       Impact factor: 6.600

Review 7.  The Anti-Cancer Mechanisms of Berberine: A Review.

Authors:  Ye Wang; Yanfang Liu; Xinyang Du; Hong Ma; Jing Yao
Journal:  Cancer Manag Res       Date:  2020-01-30       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.